Français
ItalianoBond Gilead Sciences 5.5% ( US375558CD39 ) in USD
| Issuer | Gilead Sciences | ||||||||
| Market price |  99.70 % ▼ |
||||||||
| Country |  United States
|
||||||||
| ISIN code |
 US375558CD39 ( in USD )
|
||||||||
| Interest rate | 5.5% per year ( payment 2 times a year) | ||||||||
| Maturity | 15/11/2054 | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | / | ||||||||
| Total amount | / | ||||||||
| Cusip | 375558CD3 | ||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||||||
| Next Coupon | 15/11/2026 ( In 81 days ) | ||||||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CD39, pays a coupon of 5.5% per year. The coupons are paid 2 times per year and the Bond maturity is 15/11/2054 The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CD39, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CD39, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||